Scott Olson - Jul 1, 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: SVP & Pres, Rhythm Management
Signature: /s/ Mai-Khoi Nguyen-Thanh, Attorney-in-Fact
Stock symbol: BSX
Transactions as of: Jul 1, 2021
Transactions value $: -$67,843
Form type: 4
Date filed: 7/6/2021, 04:10 PM
Next filing: Oct 4, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+1.77K	+13.79%	$0.00	14.6K	Jul 1, 2021	Direct	F1
transaction	BSX	Common Stock	Sale	-$29.9K	-700	-4.79%	$42.78	13.9K	Jul 1, 2021	Direct	F2
transaction	BSX	Common Stock	Tax liability	-$37.9K	-874	-6.28%	$43.36	13K	Jul 1, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-1.77K	-24.99%	$0.00	5.32K	Jul 1, 2021	Common Stock	1.77K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F3	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2021, the first anniversary of the date of grant.